Because these medications affect the digestive system, it is important to start at a low dose and gradually increase it under medical supervision
In other medications, this is a desirable effect to assist in disease management such as sodiumglucose transport protein 2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor (GLP-1) agonists when used to treat type 2 diabetes mellitus and topiramate when used for migraine prophylaxis and for patients with binge-eating disorder
N.KingS
European journal of translational myology 25 , 3548, (2015)
Hedenstierna and Larsson, 2012), these disturbances, each with a different set of causes, may also contribute to high intra-abdominal pressure, and thus when ameliorated/reduced, they may indicate the beneficial effect of BPC 157 therapy in cases of secondary high intra-abdominal pressure
As described in the Results section, no adverse reactions related to GSSG were reported during the study period